Results for trombocytaggregationen translation from Swedish to English

Swedish

Translate

trombocytaggregationen

Translate

English

Translate
Translate

Instantly translate texts, documents and voice with Lara

Translate now

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Swedish

English

Info

Swedish

telavancin har ingen effekt på trombocytaggregationen.

English

telavancin has no effect on platelet aggregation.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Swedish

likartad eller högre hämning av trombocytaggregationen observerades med prasugrel.

English

similar or higher inhibition of platelet aggregation was observed with prasugrel.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Swedish

integrilin hämmar trombocytaggregationen, men tycks inte påverka trombocyternas viabilitet.

English

integrilin inhibits platelet aggregation, but does not appear to affect the viability of platelets.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Swedish

trombocytopeni integrilin hämmar trombocytaggregationen, men tycks inte påverka trombocyternas viabilitet.

English

thrombocytopaenia integrilin inhibits platelet aggregation, but does not appear to affect the viability of platelets.

Last Update: 2012-04-11
Usage Frequency: 2
Quality:

Swedish

mer än 98 % av försökspersonerna hade ≥ 20 % hämning av trombocytaggregationen vid underhållsdosering.

English

more than 98% of subjects had ≥ 20% inhibition of platelet aggregation during maintenance dosing.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Swedish

apixaban har ingen direkt påverkan på trombocytaggregationen men hämmar indirekt trombocytaggregation som induceras av trombin.

English

apixaban has no direct effects on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Swedish

förändringar under behandling med eptifibatid beror på dess kända farmakologiska verkan, dvs hämning av trombocytaggregationen.

English

changes during eptifibatide treatment result from its known pharmacological action, i.e., inhibition of platelet aggregation.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Swedish

atorvastatin (80 mg dagligen) förändrade inte farmakokinetiken av prasugrel och dess hämning av trombocytaggregationen.

English

atorvastatin (80 mg daily) did not alter the pharmacokinetics of prasugrel and its inhibition of platelet aggregation.

Last Update: 2012-04-11
Usage Frequency: 2
Quality:

Swedish

därför förväntas inte statiner som är substrat till cyp3a ha någon effekt på prasugrels farmakokinetik eller dess hämning av trombocytaggregationen.

English

therefore, statins that are substrates of cyp3a are not anticipated to have an effect on the pharmacokinetics of prasugrel or its inhibition of platelet aggregation.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Swedish

hos råtta hämmade dasatinib trombocytaggregationen in vitro och förlängde blödningstiden i ytterhuden in vivo, men framkallade inte någon spontan blödning.

English

in rats, dasatinib inhibited platelet aggregation in vitro and prolonged cuticle bleeding time in vivo, but did not invoke spontaneous haemorrhage.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Swedish

en studie på friska försökspersoner mellan 20 och 80 år visade att ålder inte hade någon signifikant effekt på prasugrels farmakokinetik eller dess hämning av trombocytaggregationen.

English

in a study of healthy subjects between the ages of 20 and 80 years, age had no significant effect on pharmacokinetics of prasugrel or its inhibition of platelet aggregation.

Last Update: 2012-04-11
Usage Frequency: 2
Quality:

Swedish

i båda fallen erhöll 89% av friska försökspersoner och patienter med stabil ateroskleros minst 50% hämning av trombocytaggregationen vid 1 timme.

English

the maximum inhibition by prasugrel of adp-induced platelet aggregation is 83% with 5 µm adp and 79% with 20 µm adp, in both cases with 89% of healthy subjects and patients with stable atherosclerosis achieving at least 50% inhibition of platelet aggregation by 1 hour.

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Swedish

en enstaka intravenös bolusdos av ofraktionerat heparin (100 e/ kg) förändrade inte markant den prasugrelmedierade hämningen av trombocytaggregationen.

English

a single intravenous bolus dose of unfractionated heparin (100 u/ kg) did not significantly alter the prasugrel-mediated inhibition of platelet aggregation.

Last Update: 2012-04-11
Usage Frequency: 2
Quality:

Swedish

trombocytaggregationen återvände gradvis till utgångsvärdet inom 7 till 9 dagar efter behandling med en enstaka laddningsdos prasugrel på 60 mg, och efter 5 dagar efter utsättande av underhållsdosen vid steady-state.

English

platelet aggregation gradually returned to baseline values after treatment in 7 to 9 days after administration of a single 60 mg loading dose of prasugrel and in 5 days following discontinuation of maintenance dosing at steady-state.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Swedish

eptifibatid hämmar trombocytaggregationen på ett dos- och koncentrationsberoende sätt vilket visats genom ex vivo trombocytaggregation med hjälp av adenosindifosfat (adp) och andra agonister som inducerar trombocytaggregation.

English

eptifibatide inhibits platelet aggregation in a dose- and concentration-dependent manner as demonstrated by ex vivo platelet aggregation using adenosine diphosphate (adp) and other agonists to induce platelet aggregation.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Swedish

hos friska försökspersoner, patienter med stabil ateroskleros och patienter med acs som erhållit efient konstaterades ingen relevant effekt på prasugrels farmakokinetik eller dess hämning av trombocytaggregationen orsakad av genetisk variation i cyp3a5, cyp2b6, cyp2c9 eller cyp2c19.

English

in healthy subjects, patients with stable atherosclerosis, and patients with acs receiving efient, there was no relevant effect of genetic variation in cyp3a5, cyp2b6, cyp2c9, or cyp2c19 on the pharmacokinetics of prasugrel or its inhibition of platelet aggregation.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Swedish

prasugrel-medierad hämning av trombocytaggregationen visar låg variabilitet mellan individer (9 %) och inom individer (12 %) med både 5 µm och 20 µm adp.

English

prasugrel-mediated inhibition of platelet aggregation exhibits low between-subject (9%) and within-subject (12%) variability with both 5 µm and 20 µm adp.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Swedish

prasugrel- medierad hämning av trombocytaggregationen var också lika hos patienter med terminal njursjukdom, som krävde hemodialys, jämfört med friska försökspersoner, dock minskade cmax och auc av den aktiva metaboliten med 51% respektive 42% hos esrd patienter.

English

11 similar in patients with esrd who required haemodialysis compared to healthy subjects, although cmax and auc of the active metabolite decreased 51% and 42%, respectively, in esrd patients.

Last Update: 2012-04-11
Usage Frequency: 4
Quality:

Get a better translation with
8,641,999,596 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK